SEC Form 4 · accession 0001481436-15-000005
TENAX THERAPEUTICS, INC. · TENX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael B Jebsen
Officer — CFO
Period of report
Oct 31, 2015
Accepted (ET)
Nov 9, 2015 · 1:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000034956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common stock | Oct 31, 2015 | D | 49 | $3.19 | A | 68,035 | D |
Table II — derivative securities
No Table II lines on this filing.